These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3091897)

  • 1. Presence of activated T-cells with a T8+ M1+ Leu 7+ surface phenotype in invaded lymph nodes from patients with solid tumors.
    Cozzolino F; Torcia M; Castigli E; Selli C; Giordani R; Carossino AM; Squadrelli M; Cagnoni M; Pistoia V; Ferrarini M
    J Natl Cancer Inst; 1986 Sep; 77(3):637-41. PubMed ID: 3091897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.
    Cozzolino F; Torcia M; Carossino AM; Giordani R; Selli C; Talini G; Reali E; Novelli A; Pistoia V; Ferrarini M
    J Exp Med; 1987 Aug; 166(2):303-18. PubMed ID: 2955070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
    Kansas GS; Wood GS; Fishwild DM; Engleman EG
    J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered lymphocyte populations in tumour invaded nodes of breast cancer patients.
    Alam SM; Clark JS; George WD; Campbell AM
    Immunol Lett; 1993 Mar; 35(3):229-34. PubMed ID: 8390399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistocytochemical correlation of DAP IV-CD 26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues.
    Cozzi M; Gloghini A; Volpe R; Carbone A
    Br J Haematol; 1990 Jul; 75(3):325-32. PubMed ID: 1974815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu-6-expressing cells in lymph nodes: dendritic cells phenotypically similar to interdigitating cells.
    Weiss LM; Beckstead JH; Warnke RA; Wood GS
    Hum Pathol; 1986 Feb; 17(2):179-84. PubMed ID: 3081423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracortical immunoregulatory subpopulations in lymph nodes from homosexual men with persistent generalized lymphadenopathy.
    Lash RH; Tubbs RR; Calabrese LH
    Hum Pathol; 1988 Apr; 19(4):419-22. PubMed ID: 3284806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T8 and T3 surface glycoproteins in human T-cell mediation of leukocyte adherence inhibition to extracts of autologous cancer.
    Labateya N; Thomson DM
    J Natl Cancer Inst; 1985 Dec; 75(6):987-94. PubMed ID: 2999497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Plasmacytoid T cells" in Castleman's disease. Immunohistologic phenotype.
    Harris NL; Bhan AK
    Am J Surg Pathol; 1987 Feb; 11(2):109-13. PubMed ID: 3544885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of B cell growth factor by a Leu-7+, OKM1+ non-T cell with the features of large granular lymphocytes (LGL).
    Pistoia V; Cozzolino F; Torcia M; Castigli E; Ferrarini M
    J Immunol; 1985 May; 134(5):3179-84. PubMed ID: 3920315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of T cell subsets in human lymph nodes.
    Poppema S; Bhan AK; Reinherz EL; McCluskey RT; Schlossman SF
    J Exp Med; 1981 Jan; 153(1):30-41. PubMed ID: 6450262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.
    Kadin ME; Muramoto L; Said J
    Am J Pathol; 1988 Feb; 130(2):345-53. PubMed ID: 2963547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562.
    Phillips JH; Lanier LL
    J Exp Med; 1985 Jun; 161(6):1464-82. PubMed ID: 3159818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells.
    Herait P; Ganem G; Lipinski M; Carlu C; Micheau C; Schwaab G; De-The G; Tursz T
    Br J Cancer; 1987 Feb; 55(2):135-9. PubMed ID: 3545275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leu-M1 antigen expression in advanced (tumor) stage mycosis fungoides.
    Wieczorek R; Suhrland M; Ramsay D; Reed ML; Knowles DM
    Am J Clin Pathol; 1986 Jul; 86(1):25-32. PubMed ID: 3088980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique.
    Namikawa R; Suchi T; Ueda R; Itoh G; Koike K; Ota K; Takahashi T
    Am J Pathol; 1987 May; 127(2):279-87. PubMed ID: 3555102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity.
    Bagnasco M; Venuti D; Paolieri F; Torre G; Ferrini S; Canonica GW
    J Clin Endocrinol Metab; 1989 Oct; 69(4):832-6. PubMed ID: 2789232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
    Abo T; Cooper MD; Balch CM
    J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.